{"name": "Pro-Cure Therapeutics",
 "permalink": "pro-cure-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/pro-cure-therapeutics",
 "homepage_url": "http://www.pro-cure.uk.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@pro-cure.uk.com",
 "phone_number": "44-(0)1904-435125",
 "description": "",
 "created_at": "Mon Mar 22 03:48:37 UTC 2010",
 "updated_at": "Wed Jul 07 03:25:12 UTC 2010",
 "overview": "\u003Cp\u003EPro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       47],
      "assets/images/resized/0008/1173/81173v1-max-150x150.jpg"],
     [[228,
       72],
      "assets/images/resized/0008/1173/81173v1-max-250x250.jpg"],
     [[228,
       72],
      "assets/images/resized/0008/1173/81173v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a31.63M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.pro-cure.uk.com/news.php?newsID=1",
    "source_description": "University of York spin-out secures \u00c2\u00a3550,000 investment in hunt for cancer treatments. ",
    "raised_amount": 550000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2007,
    "funded_month": 11,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "White Rose Technology Seedcorn Fund",
         "permalink": "white-rose-technology-seedcorn-fund",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0008/0836/80836v1-max-150x150.jpg"],
             [[250,
               62],
              "assets/images/resized/0008/0836/80836v1-max-250x250.jpg"],
             [[261,
               65],
              "assets/images/resized/0008/0836/80836v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Yorkshire Cancer Research",
         "permalink": "yorkshire-cancer-research",
         "image":
          {"available_sizes":
            [[[96,
               109],
              "assets/images/resized/0008/1175/81175v1-max-150x150.jpg"],
             [[96,
               109],
              "assets/images/resized/0008/1175/81175v1-max-250x250.jpg"],
             [[96,
               109],
              "assets/images/resized/0008/1175/81175v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.pro-cure.uk.com/news.php?newsID=8",
    "source_description": "Pro-Cure Therapeutics Limited Secures Further Funding and Strengthens its Board (Press Release 13 April 2010) ",
    "raised_amount": 1080000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 13,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "YFM Venture Finance",
         "permalink": "yfm-venture-finance",
         "image":
          {"available_sizes":
            [[[122,
               73],
              "assets/images/resized/0004/5925/45925v1-max-150x150.jpg"],
             [[122,
               73],
              "assets/images/resized/0004/5925/45925v1-max-250x250.jpg"],
             [[122,
               73],
              "assets/images/resized/0004/5925/45925v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Yorkshire Cancer Research",
         "permalink": "yorkshire-cancer-research",
         "image":
          {"available_sizes":
            [[[96,
               109],
              "assets/images/resized/0008/1175/81175v1-max-150x150.jpg"],
             [[96,
               109],
              "assets/images/resized/0008/1175/81175v1-max-250x250.jpg"],
             [[96,
               109],
              "assets/images/resized/0008/1175/81175v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Maven Capital Partners",
         "permalink": "maven-capital-partners",
         "image":
          {"available_sizes":
            [[[142,
               88],
              "assets/images/resized/0006/0870/60870v2-max-150x150.jpg"],
             [[142,
               88],
              "assets/images/resized/0006/0870/60870v2-max-250x250.jpg"],
             [[142,
               88],
              "assets/images/resized/0006/0870/60870v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Innovation Way",
    "address2": "Heslington",
    "zip_code": "YO10 5NY",
    "city": "York",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        101],
       "assets/images/resized/0008/1174/81174v1-max-150x150.jpg"],
      [[250,
        169],
       "assets/images/resized/0008/1174/81174v1-max-250x250.jpg"],
      [[450,
        304],
       "assets/images/resized/0008/1174/81174v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}